{"name": "Leonardo Biosystems",
 "permalink": "leonardo-biosystems",
 "crunchbase_url": "http://www.crunchbase.com/company/leonardo-biosystems",
 "homepage_url": "http://www.leonardobiosystems.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@leonardobiosystems.com",
 "phone_number": "713-409-1131",
 "description": "",
 "created_at": "Tue Nov 15 04:04:38 UTC 2011",
 "updated_at": "Tue Nov 15 04:04:36 UTC 2011",
 "overview": "\u003Cp\u003ELeonardo Biosystems, Inc., a Houston, TX-based provider of a proprietary multistage drug delivery platform initially targeting the treatment of cancer.\u003C/p\u003E\n\n\u003Cp\u003EFounded in 2005 and based on a technology of Dr. Mauro Ferrari, President of the Methodist Hospital Research Institute in Houston, Leonardo has a multi-stage delivery platform that consists of fully biodegradable, porous silicon particles (smaller than a red blood cell), which can be loaded with a diverse array of secondary nanoparticles such as liposomes, micelles, carbon nanotubes, dendrimers and metallic nanoparticles. These particles can be designed to seek out tumor vasculature and can be tuned to create an intravascular depot, providing sustained release following a single intravenous injection.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0016/2401/162401v1-max-150x150.png"],
     [[250,
       76],
      "assets/images/resized/0016/2401/162401v1-max-250x250.png"],
     [[278,
       85],
      "assets/images/resized/0016/2401/162401v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Bruce",
      "last_name": "D. Given",
      "permalink": "bruce-d-given",
      "image": null}},
   {"is_past": false,
    "title": "CTO",
    "person":
     {"first_name": "Jason",
      "last_name": "H. Sakamoto",
      "permalink": "jason-h-sakamoto",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.25M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/11/leonardo-biosystems-receives-1-25m-texas-emerging-technology-fund.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Leonardo Biosystems Receives $1.25M From Texas Emerging Technology Fund",
    "raised_amount": 1250000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 11,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "The Texas Emerging Technology Fund",
         "permalink": "the-texas-emerging-technology-fund",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0003/0335/30335v2-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0003/0335/30335v2-max-250x250.png"],
             [[302,
               120],
              "assets/images/resized/0003/0335/30335v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "7000 Fannin St",
    "address2": "Suite 1930",
    "zip_code": "77030 ",
    "city": "Houston",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}